首页> 外文OA文献 >Niclosamide and Bicalutamide Combination Treatment Overcomes Enzalutamide- and Bicalutamide-Resistant Prostate Cancer

【2h】

Niclosamide and Bicalutamide Combination Treatment Overcomes Enzalutamide- and Bicalutamide-Resistant Prostate Cancer

机译：Niclosamide和Bicalutamide联合治疗克服了依甲醛胺和耐酪蛋白质抗性前列腺癌

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Chengfei Liu; Cameron M. Armstrong; Wei Lou; Alan P. Lombard; Vito Cucchiara; Xinwei Gu; Joy C. Yang; Nagalakshmi Nadiminty; Chong-xian Pan; Christopher P. Evans; Allen C. Gao;
展开▼
作者单位

展开▼
年度 2017
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Niclosamide and Bicalutamide Combination Treatment Overcomes Enzalutamide- and Bicalutamide-Resistant Prostate Cancer [J] . Liu Chengfei, Armstrong Cameron M., Lou Wei, Molecular cancer therapeutics . 2017,第8期

机译：Niclosamide和Bicalutamide联合治疗克服依甲酰胺和耐酪蛋白质抗性前列腺癌
2. Hydroxyflutamide enhances cellular sensitivity to 5-fluorouracil by suppressing thymidylate synthase expression in bicalutamide-resistant human prostate cancer cells [J] . Rumi Kawabata, Shinji Oie, Toshinori Oka, International journal of oncology . 2011,第3期

机译：羟氟甲酰胺通过抑制耐比卡鲁胺的人前列腺癌细胞中的胸苷酸合酶表达，增强了对5-氟尿嘧啶的细胞敏感性
3. A randomized phase II efficacy and safety study of vandetanib (ZD6474) in combination with bicalutamide versus bicalutamide alone in patients with chemotherapy na?ve castration-resistant prostate cancer [J] . AzadA.A., BeardsleyE.K., HotteS.J., Investigational new drugs. . 2014,第4期

机译：凡德他尼（ZD6474）联合比卡鲁胺与单独使用比卡鲁胺对患有单纯去势抵抗性前列腺癌的患者进行的随机II期疗效和安全性研究
4. Niclosamide loaded cationic Solid Lipid Nanoparticles for treatment of Cancer [C] . Nishant Kumar Jain, Rohit Srivastava, VGM Naidu International Conference on Nanotechnology . 2016

机译：硝氯酰胺负载的阳离子固体脂质纳米颗粒用于治疗癌症
5. Combination nanomedicine targeting cancer stem cells and bulk tumor cells for treatment of prostate cancer. [D] . Zhou, Yan. 2014

机译：靶向癌症干细胞和大块肿瘤细胞的纳米药物联合治疗前列腺癌。
6. Niclosamide and bicalutamide combination treatment overcomes enzalutamide and bicalutamide resistant prostate cancer [O] . Chengfei Liu, Cameron M. Armstrong, Wei Lou, -1

机译：尼氯酰胺和比卡鲁胺联合治疗可克服恩杂鲁胺和比卡鲁胺耐药的前列腺癌
7. Superior Anti-tumor Efficacy of Bicalutamide 80 mg in Combination with a Luteinizing Hormone-releasing Hormone (LHRH) Agonist Versus LHRH Agonist Monotherapy as First-line Treatment for Advanced Prostate Cancer: Interim Results of a Randomized Study in Japanese Patients [O] . H. Akaza 2004

机译：与丁黄激素释放激素（LHRH）激动剂（LHRH）激动剂与LHRH激动剂单疗作用相结合的优异的抗肿瘤效果与LHRH激动剂单疗法为一线治疗前列腺癌：日本患者随机研究的中期结果
8. Targeted Approach to Overcoming Treatment Resistance in Advanced Prostate Cancer. [R] . Scarpinato, K. 2015

机译：克服晚期前列腺癌治疗抵抗的有针对性的方法。

Niclosamide and Bicalutamide Combination Treatment Overcomes Enzalutamide- and Bicalutamide-Resistant Prostate Cancer

著录项

引文网络

相似文献

相关主题

期刊订阅